Cargando…
Sorcin is an early marker of neurodegeneration, Ca(2+) dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases
Dysregulation of calcium signaling is emerging as a key feature in the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), and targeting this process may be therapeutically beneficial. Under this perspective, it is imp...
Autores principales: | Genovese, Ilaria, Giamogante, Flavia, Barazzuol, Lucia, Battista, Theo, Fiorillo, Annarita, Vicario, Mattia, D’Alessandro, Giuseppina, Cipriani, Raffaela, Limatola, Cristina, Rossi, Daniela, Sorrentino, Vincenzo, Poser, Elena, Mosca, Luciana, Squitieri, Ferdinando, Perluigi, Marzia, Arena, Andrea, van Petegem, Filip, Tito, Claudia, Fazi, Francesco, Giorgi, Carlotta, Calì, Tito, Ilari, Andrea, Colotti, Gianni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566454/ https://www.ncbi.nlm.nih.gov/pubmed/33060591 http://dx.doi.org/10.1038/s41419-020-03063-y |
Ejemplares similares
-
Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
por: Genovese, Ilaria, et al.
Publicado: (2017) -
Sorcin, a Calcium Binding Protein Involved in the Multidrug Resistance Mechanisms in Cancer Cells
por: Colotti, Gianni, et al.
Publicado: (2014) -
Structural basis of Sorcin-mediated calcium-dependent signal transduction
por: Ilari, Andrea, et al.
Publicado: (2015) -
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways
por: Tito, Claudia, et al.
Publicado: (2023) -
Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
por: Battista, Theo, et al.
Publicado: (2020)